We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$82.3B
AUM Growth
+$3.23B
(+4.1%)
Cap. Flow
-$7.73B
Cap. Flow
% of AUM
-9.4%
Top 10 Holdings %
Top 10 Hldgs %
24.03%
Holding
2,474
New
201
Increased
562
Reduced
953
Closed
424
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$983M |
| 2 |
Exelon
EXC
|
+$595M |
| 3 |
Broadcom
AVGO
|
+$486M |
| 4 |
CRH
CRH
|
+$387M |
| 5 |
Marvell Technology
MRVL
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$795M |
| 2 |
Norfolk Southern
NSC
|
+$559M |
| 3 |
PPL
PPL Corp
PPL
|
+$355M |
| 4 |
Union Pacific
UNP
|
+$328M |
| 5 |
Cisco
CSCO
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.45% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 13.09% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Essent Group
ESNT
$6.32B
| $71K | ﹤0.01% |
1,195
-2,080
| -64% | -$113K |
|
1477
Kiniksa Pharmaceuticals
KNSA
$5.92B
| $71K | ﹤0.01% |
+3,607
| New | +$70.4K |
|
|
BBBY
1478
Bed Bath & Beyond
BBBY
$441M
| $70K | ﹤0.01% |
2,181
+2,172
| +24,133% | +$55.9K |
|
1479
IBEX
IBEX
$492M
| $70K | ﹤0.01% |
4,591
-630
| -12% | -$10.3K |
|
1480
Loews
L
$23.6B
| $70K | ﹤0.01% |
900
| – | – |
|
1481
Impinj
PI
$5.54B
| $70K | ﹤0.01% |
550
-38
| -6% | -$3.99K |
|
1482
Planet Fitness
PLNT
$3.97B
| $70K | ﹤0.01% |
1,123
+17
| +2% | +$1.14K |
|
1483
Red Violet
RDVT
$945M
| $70K | ﹤0.01% |
3,614
+2,816
| +353% | +$51.6K |
|
|
GRTS
1484
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $70K | ﹤0.01% |
+27,461
| New | +$67.1K |
|
|
JWN
1485
DELISTED
Nordstrom
JWN
| $69K | ﹤0.01% |
3,437
-7
| -0.2% | -$132 |
|
1486
MannKind Corp
MNKD
$1.32B
| $69K | ﹤0.01% |
15,372
-647,351
| -98% | -$2.54M |
|
1487
Ocugen
OCGN
$427M
| $69K | ﹤0.01% |
43,019
-23,743
| -36% | -$19.9K |
|
1488
Protagonist Therapeutics
PTGX
$9.41B
| $69K | ﹤0.01% |
+2,415
| New | +$65.7K |
|
1489
Rio Tinto
RIO
$165B
| $69K | ﹤0.01% |
1,096
+13
| +1% | +$870 |
|
1490
ImmunityBio
IBRX
$7.96B
| $68K | ﹤0.01% |
13,019
+6,593
| +103% | +$29.9K |
|
|
ITCI
1491
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $68K | ﹤0.01% |
997
| – | – |
|
|
SEMR
1492
DELISTED
Semrush
SEMR
| $67K | ﹤0.01% |
5,055
-132
| -3% | -$1.59K |
|
1493
Astec Industries
ASTE
$1.02B
| $66K | ﹤0.01% |
+1,521
| New | +$56.7K |
|
1494
BioCryst Pharmaceuticals
BCRX
$2.41B
| $66K | ﹤0.01% |
13,179
-964
| -7% | -$5.42K |
|
1495
BioMarin Pharmaceuticals
BMRN
$12.1B
| $66K | ﹤0.01% |
774
-212
| -22% | -$19K |
|
1496
Old Republic International
ORI
$10.4B
| $66K | ﹤0.01% |
2,198
-33,622
| -94% | -$977K |
|
|
SKX
1497
DELISTED
Skechers
SKX
| $66K | ﹤0.01% |
1,107
-6
| -0.5% | -$366 |
|
1498
Textron
TXT
$15.4B
| $66K | ﹤0.01% |
695
+253
| +57% | +$21.9K |
|
1499
Black Hills Corp
BKH
$5.72B
| $65K | ﹤0.01% |
1,194
+28
| +2% | +$1.47K |
|
1500
Peabody Energy
BTU
$2.87B
| $65K | ﹤0.01% |
2,707
-204
| -7% | -$5.13K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Lazard Asset Management held 2,474 positions worth $82.3B, up 4.1% from $79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $7.73B in Q1 2024, closing 424 positions and reducing 953 holdings. Its most notable exit was PPL Corp, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in GMO US Quality ETF worth $10.8M.
- Lazard Asset Management's largest Q1 2024 buy was GMO US Quality ETF: 362,290 shares worth $10.8M.
- Lazard Asset Management added most to Apple in Q1 2024, an estimated $983M increase.
- Lazard Asset Management's biggest Q1 2024 reduction was Alphabet (Google) Class A, cutting an estimated $795M.
- Lazard Asset Management fully exited PPL Corp in Q1 2024, selling an estimated $355M.
- Lazard Asset Management's ten largest holdings make up 24% of its $82.3B portfolio in Q1 2024.
- Lazard Asset Management opened 201 new positions and closed 424 in Q1 2024.
- Lazard Asset Management's portfolio value rose 4.1% quarter-over-quarter to $82.3B.
Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.